1World Health Organization, Difinition, Dragnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva: World Health Organization, 1999.
5Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly[J]. Diabetes,2001,50(10):2384-2389.
6Freeman DJ, Norrie J, Caslake MJ,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study[J].Diabetes,2002,51(5) :1596-1600.
7Festa A, D'Agostino R Jr, Howard G,et al. Chronic subclinical inflammation as part of the insulin resistance sydrome. The Insulin Resistance Atherosclerosis Study (IRAS) [J]. Circulation,2000,102(1) :42-47.
8Frohlich M,Imhof A,Berg G,et al. Association between C-reactive protein and features of the metabolic syndrome:a population-based study [J]. Diabetes Care, 2000, 23 ( 12 ) : 1835-1839.
9Visser M, Bouter LM, Geraldine MM, et al. Elevated C-reactive protein levels in overweight and obese adults[J], JAMA,1999,282(22) :2131-2135.
10Calandra T, Bernhagen J, Mitchell RA,et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor[J], J Exp Med, 1994,179(6) :1895-1902.
